Business context and reporting period
The supplied filing is Dr Pepper Snapple Group, Inc.’s unaudited Form 10-Q for the quarter ended September 30, 2012—not a filing in the name of Keurig Dr Pepper Inc. The company reports Beverage Concentrates, Packaged Beverages, and Latin America Beverages segments.
Financial performance
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Net sales | $1.528 billion | $1.529 billion | $4.511 billion | $4.442 billion |
| Gross profit / margin | $902 million / 59.0% | $857 million / 56.0% | $2.616 billion / 58.0% | $2.561 billion / 57.7% |
| Operating income / margin | $308 million / 20.1% | $261 million / 17.1% | $800 million / 17.7% | $753 million / 17.0% |
| Net income | $179 million | $154 million | $459 million | $440 million |
| Diluted EPS | $0.84 | $0.71 | $2.15 | $1.97 |
For the nine months, operating cash flow was $264 million, down from $580 million; capital expenditures were $143 million and cash used in financing was $442 million. Cash at September 30 was $383 million, versus $701 million at year-end 2011. Management attributed the operating cash-flow decline primarily to $531 million of tax payments related to PepsiCo and Coca-Cola licensing agreements, partly offset by working-capital improvements.
At September 30, total liabilities were $6.671 billion and stockholders’ equity was $2.318 billion. Long-term obligations were $2.766 billion, including $701 million current and $2.065 billion long-term; this includes capital leases. Senior unsecured notes had a $2.710 billion carrying amount. Current assets of $1.396 billion compared with current liabilities of $1.736 billion. The company reported no revolver borrowings and stated it was in compliance with debt covenants.
Material changes versus prior comparable periods
- Q3 sales were essentially flat, while net income rose 16% and diluted EPS rose 18%. Higher pricing, favorable mix, productivity, and commodity-derivative mark-to-market gains lifted gross margin; volumes remained weak.
- For the first nine months, sales increased 2%, net income increased 4%, and diluted EPS increased 9%. Gross margin improved 0.3 percentage points.
- Q3 bottler case sales declined 3%; nine-month bottler case sales declined 1%. Q3 CSD volume fell 2% and non-carbonated beverage volume fell 5%.
- Nine-month segment sales were $888 million in Beverage Concentrates, $3.314 billion in Packaged Beverages, and $309 million in Latin America Beverages. Segment operating profit was respectively $552 million, $408 million, and $37 million.
- Cash returned to shareholders included $262 million of share repurchases and $213 million of dividends during the first nine months. The company repurchased 6.3 million shares; $1.110 billion remained under the repurchase authorization.
Outlook, commentary, risks, and unusual items
- Management expected 2012 capital expenditures, net of disposals, to be approximately 3.75% of net sales and said operating cash flows should cover anticipated obligations for the next 12 months.
- The company intended to refinance its $450 million of 2.35% notes due December 21, 2012. It also had $250 million of 6.12% notes due May 1, 2013. A new five-year $500 million revolver was established in September 2012, with $493 million available at quarter-end.
- Q3 gross profit benefited from $15 million of unrealized commodity-derivative gains, compared with $9 million of unrealized losses in Q3 2011. Nine-month results included $15 million of such gains versus $14 million of losses in the prior-year period. These are valuation items and may reverse.
- Key demand and cost exposures include lower beverage volumes, competition limiting recovery of commodity-cost increases, foreign-exchange movements, and seasonality. Management cited pricing and reduced promotions as contributors to volume declines in several brands.
- The company accrued approximately $18 million for an age-discrimination jury verdict and appealed the judgment. It reported potential Superfund cleanup exposure in New Jersey; costs had not been determined, and approximately $425,000 had been paid through September 30, 2012. Management did not expect pending legal matters to have a material adverse effect.
- Management reported no material changes to previously disclosed risk factors. Forward-looking statements are subject to uncertainty; the filing does not provide specific full-year revenue or EPS guidance.
Investor facts to verify
- Confirm the issuer identity: this document names Dr Pepper Snapple Group, Inc., despite the request identifying Keurig Dr Pepper Inc.
- Track whether the December 2012 notes were refinanced and the resulting interest cost and liquidity position.
- Assess whether pricing and mix can offset continued volume weakness, particularly in Packaged Beverages and non-carbonated products.
- Separate underlying operating trends from commodity-derivative mark-to-market gains and the unusual licensing-related tax payments.
- Review the $18 million legal accrual, appeal outcome, and any updates to environmental contingencies.